In localized and de novo metastatic prostate cancer, three genes, DOCK2, HAPLN3, and FBXO30, were found to be specifically hypermethylated in prostate cancer tissues using MS‐ddPCR [44]. This evidence concerns the gene HAPLN3 and Familial prostate cancer.